friday zeiss presentation - wayne caulder · 2018-04-04 · key needs of ophthalmic surgeons today...

1

ZEISS Insights

2

ZEISSA Global Leader

ZEISS is a company of market-leading business groups in the optical and optoelectronic industries.

The Group

ZEISS Insights June 2017

2

3

A Company Built on the Strong Values of Our Founders

The vision Cutting-edge research

Social responsibility

Extreme precision and maximum quality

Carl Zeiss Ernst Abbe

ZEISS heritage and future orientation• Strong brand

• Continued innovation

• Strong and sustainable setup

Yesterday, Today and Tomorrow


4

ZEISSAround the World

Headquarters

Oberkochen, Germany

Around

25 R&D centers

30 production sites

50 sales & service sitesAs of 30 September 2016.


3

5

Segments2015/16

**As of 30 September 2016 **The values deviate from the published figures of Carl Zeiss Meditec AG as a result of different consolidation models.

Medical Technology**

1.290* billion euros revenue ≈ 4,300 employees

682 million euros revenue (1st half year 2016/17)

Semiconductor Manufacturing Technology

972* million euros revenue ≈ 2,700 employees


Vision Care/Consumer Products



Research & Quality Technology




6

ZEISS Innovation Leadership

*As of 30 September 2016

447 new patent applications

≈10% of revenue invested in research and development

10% of employees (worldwide) in research and development

7,793 Patents*


4

7

ZEISS Innovation Leadership

“Innovation is a way of life at ZEISS…

Optical technologies are key for

our future…will increasingly appear

in our daily lives.”

-- Dr. Michael Kaschke

President and CEO of ZEISS


8

As of 30 September 2015

ZEISS lithography optics enable semiconductor structures

4,000 times thinner than a strand of human hair.

ZEISSSemiconductor Manufacturing and Research & Quality Technology

35 Nobel Laureates put their trust in ZEISS microscopes


5

9

ZEISSVision Care/Consumer Products


3 Technical Oscarshonored ZEISS cine lenses for helping leading movie makers capture perfect moments on film

Every second 2 people

decide to purchase eyeglass lenses from ZEISS


Ophthalmic Devices Microsurgery Comprehensive solutions to diagnose

and treat eye diseases

Systems and consumables for cataract, retinal and refractive surgery

Focus on networking of systems and the integrated management of data, to make workflows in hospitals and medical practices efficient

Complete product range of visualization solutions for minimally invasive surgical treatments (e.g. Neuro, ENT, spinal, dental)

Intraoperative diagnostics to enhance effectiveness and safety of surgical procedures complete with cutting-edge video technology and three-dimensional imaging

As a world-leading medical technology company, we drive progress in medicine,

enabling doctors to achieve the best possible outcomes for their patients

Revenue

Ophthalmic Diagnostics Refractive Laser Surgery Surgical Ophthalmology Visualization Surgical Oncology

Revenue split 2015/16

ZEISS Medical TechnologyDriving Progress in Medicine through Innovation

10ZEISS Insights June 2017

6

11

ZEISS Ophthalmic DevicesTotal Vision Care

First Glasses Refractive Surgery

Managing Eye Diseases

Glaucoma to Retina

Cataract and Retina

Surgery

Reading Glasses

Innovations for superior vision care across all stages of life


12


15 million cataract operations are performed all over the world every year using surgical systems from ZEISS

ZEISSMedical Technology


7

13

75% of all cataract patients come into contact with a ZEISS product during their treatment



14

More than 750,000 SMILE laser vision correction procedures have been performed in over 600 clinics in 62 countries



8

15

More than 50% of OCTsin ophthalmic practices are ZEISS OCTs

1st OCT innovations:• 1st Ophthalmic OCT commercially available (1996)

• 1st Integrated Intraoperative OCT (2014)

• 1st Swept Source OCT in biometry (2014)

• 1st OCT Angiography to receive FDA Clearance (2015)

• 1st Swept Source OCT for posterior ocular imaging to

receive FDA Clearance (2016)



16

ZEISS Medical TechnologyInnovations Shaping Neurosurgery and Dental Surgery Today

NEUROSURGERY

ZEISS KINEVO 900 The Robotic Visualization System

DENTAL

ZEISS EXTARO 300Breakthrough Dental Visualization


9

17

ZEISS Medical TechnologyInnovation Shaping Ophthalmology

1857 1872 1894 1902 1912 1923 1953 1973 1977 1994 2009 2012 2013 2014 20151996 2000

ReLEx SMILE, VisuMax Femtosecond laser

1st OCT

1st surgical microscope

2016

1st

Slit Lamp

HFA Perimeter

IOLMasteroptical biometer

AT LISA & AT LISA toricMicro-incisionIOLs

OPMI LUMERAsurgical microscope

2017

PLEX EliteSwept Source OCT

1st Integrated Intraoperative OCT

1st OCT Angiography FDA Approved

IOLMaster 700 w/ Barrett Suite

CALLISTO eyeComputer-guided toric alignment

FORUM Data Management

Ultra Widefield Imaging

AngioPlexMetrix

IOLMaster 700Swept Source Biometry

“All-in-One” Surgical Microscope

EDoF IOLs


18

OPHTHALMIC DIAGNOSTICS

• AngioPlex OCT Angiography

• AngioPlex Metrix

• ARI Network Open Innovations and PLEX Elite Swept Source OCT

• Ultra Widefield Imaging

SURGICAL OPHTHALMOLOGY

• Integrated Intraoperative OCT

• IOLMaster SWEPT Source Biometry with Barrett Suite

• ZEISS Cataract Suite markerless w/CALLISTO eye

• CT LUCIA fully preloaded, hydrophobic C-LOOP IOL*

• AT LISA trifocal & toric IOLs*

• AT LARA EDoF*

• Broadest IOL portfolio* in the market

REFRACTIVE LASERS

• SMILE minimally-invasive LVC

• PRESBYOND *

ZEISS Medical TechnologyInnovations Shaping Ophthalmology Today


*Not available in the United States.

10

Surgical OphthalmologyKey Needs of Ophthalmic Surgeons Today

* Source: Market Scope Report. Comprehensive Report on the global IOL market, May 2016.

Surgeons need today

Increased and higher efficiency – they need to see more patients per day

Continuous improvement in patient outcomes - Target was previously 0.5D (with ~50% of patients achieving this result). New target is 0.25D*.


The ZEISS Cataract SolutionAn Integrated Approach to Cataract Surgery

IOLMaster®

700

Therapy

FORUM®

CALLISTO eye® with Z ALIGN™

OPMI LUMERA®

700CALLISTO eye®

Biometry Analysis Phacoemulsification and IOL Implantation

Gold standard in optical biometry combined with leading formula

Eye Care Data Management

With fully-integrated HD video chain

The assistant for an integrated workplace in the OR

ZEISS MICS Platform

Widest range of preloaded MICS IOLs*, innovative OVDs* and phaco technology*

OR Management



11

Broad IOL Portfolio*

to Serve Different Needs of Patients

Standard monofocal IOLs

Enhanced monofocal IOLs

Extended Depth of Focus IOLs

TrifocalIOLs

BifocalIOLs

VA

D I N

VA

D I N

VA

D I N

VA

D I N

VA

D I N

Fewest dysphotopsia,Glasses needed for reading and intermediate

Fewest dysphotopsia,Glasses needed for reading and intermediate

Spectacle independence for reading and distance

Spectacle independence for distance & inter-mediate. Less dys-photopsia than trifocals

Spectacle independence for all activities

Conservative but quality conscious patients accepting to wear glasses

Conservative patients accepting to wear glasses

Patients with a special focus on spectacle independent near vision

Patients with an active lifestyle accepting reading glasses

Premium patients with a high urge for spectacle independence

CT LUCIA 201 CT SPHERIS CT LUCIA 601CT ASPHINAAT TORBI AT LISA AT LISA tri/AT LISA tri toricAT LARA



Refractive SurgeryKey Needs of Refractive Surgeons Today

Surgeons need today

Solutions for patients’ peace of mind:̶ Reassuring safety, effectiveness and stability.

Additional / new offers to grow patient volume.


12

ZEISS Refractive LasersProduct Portfolio

ZEISS MEL 90 and PRESBYOND not available in the United States.

PRK LASIK SMILE


What is SMILE?

ZEISS ReLEx® SMILE uses the latest in laser technology to gently create a thin, contact-lens shaped layer (lenticule) just beneath the surface of the eye which is removed through a tiny opening.

US FDA Approved Indications – Indications for Use:Reduction or elimination of myopia -1.00 D to -8.00 D, with ≤ -0.50 D cylinder and MRSE -8.25 D in the eye to be treated in patients who are 22 years of age or older with documentation of stable manifest refraction over the past year.


13

SMILE Growing rapidly around the world

More than

600clinics

worldwide

More than

1000practicing surgeons

in 62 countries

More than

200peer reviewed publications

Some surgeons have already treated over

10,000eyes


26

Ophthalmic DiagnosticsKey Needs of Ophthalmic Practices Today

Practices need today

New technologies that enable more effective chronic disease management

Doctors need faster transition of meaningful innovation into practice


14

27

ZEISS Ophthalmic Diagnostics SolutionManaging & Supporting Practice Performance

FORUM® i.Profilerplus

Matrix®

ATLAS®

VISUREF

Slit LampVISUPHOR

CIRRUS ™ OCT AngioPlex®

VISUCAM®

HFA3®

Front Desk Pre-Test

Reduce data entry errors

Fast Acquisition Leading diagnostic tools

Advanced Dx Exam Consultation

Glaucoma Workplace

Retina Workplace

Therapeutic Lasers

Treatment

Leading optics At-a-glance information

Integrated digital workflow, premier diagnostic information and meaningful data display

Ongoing disease management


28

First to receive US FDA clearance

Higher image capture success rate

More than 1 minute faster in image capture

Fewer artifacts; almost 50% less

ZEISS AngioPlex OCT AngiographyOutstanding clinical & workflow performance


15

29

Transition of Innovation into Practice ZEISS Collaboration Model to Speed Innovation

Real-time collaboration for quicker turnaround of application development to market

A R I NetworkUncovering the undiscovered


Led by Global Steering Committee of physicians & researchers

Access the latest innovations in retinal imaging technology

Exchange ideas and connect with ZEISS scientists and researchers around the world to improve standard of care

30

Not all products, services or offers referenced in this presentation are approved or offered in every market and approved labeling and instructions may vary from one country to another.

COR.9025

friday zeiss presentation - wayne caulder · 2018-04-04 · key needs of ophthalmic surgeons today...

Documents